Delivery Order SPE2DB22D9143-SPE2DB23FZC58
Award Date
8/7/23
Potential Completion Date
8/28/23
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $10,120.30 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. DLA will receive 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to support the Department of Defense. Performance will occur in Park Ridge, Illinois under a schedule contract administered by DLA for pharmaceuticals and medical supplies. No subcontractors or set aside designations were identified....
The Defense Logistics Agency awarded a delivery order valued at approximately $7,464 to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The firm fixed price order calls for DMS Pharmaceutical to deliver 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to a location in Park Ridge, Illinois. The order was issued against an existing DLA contract vehicle and has a period of performance from July 5, 2023 through July 26, 2023. As the...
The Defense Logistics Agency awarded a $29,857 delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The firm fixed price order calls for DMS Pharmaceutical to deliver 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to a location in Park Ridge, Illinois. Funding is provided by DLA in support of Department of Defense requirements. The order has a period of performance from August 1, 2023 through August 22, 2023 and...
The Defense Logistics Agency awarded a $9,952 delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The firm fixed price order calls for DMS to deliver 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to a location in Park Ridge, Illinois by September 28, 2023 to support DOD requirements. No set aside designation or subcontractors were identified. The DLA manages the global supply chain for the Department of Defense,...
The Defense Logistics Agency Troop Support Medical awarded a $2,488 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The single line item delivery order is for 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension used for postsurgical analgesia. Performance will take place in Park Ridge, Illinois over a three-week period concluding in early October. No subcontractors or set-aside designations were...
The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $3,390 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 133 mg/10 ml vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension used for postsurgical analgesia. Performance will take place in Park Ridge, Illinois over a one-month period concluding in mid-September 2023. No set aside designation or subcontractors were identified. This order is...
The Defense Logistics Agency awarded a $49,762.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for EXPAREL 266 MG/20 ML vials. Under this order, DMS Pharmaceutical will deliver 20 mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to a location in Park Ridge, Illinois by September 27, 2023 in support of Department of Defense requirements. No set aside designation or subcontractors were identified. This order was issued against an...
The Defense Logistics Agency awarded a $29,857 delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The firm fixed price order calls for DMS Pharmaceutical to deliver 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to a location in Park Ridge, Illinois by September 29, 2023. The Defense Logistics Agency will provide funding for this order placed under an undisclosed multiple award contract vehicle. No...
The Defense Logistics Agency awarded a $7,464 delivery order to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. DLA will receive 20mL vials of the specified anesthetic to support Department of Defense needs. The firm fixed price order is for product delivery to a location in Park Ridge, Illinois between September 6th and 27th, 2023. No set aside designation or subcontractors were identified. DLA manages the military's supply chain as one of the largest logistics agencies,...
The Defense Logistics Agency awarded a delivery order valued at approximately $10,000 to DMS Pharmaceutical Group Inc. to supply EXPAREL 266 MG/20 ML vials. The firm fixed price order calls for DMS Pharmaceutical to deliver 20mL vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension product, to a location in Park Ridge, Illinois. Performance will take place between March 2nd and March 23rd, 2023. The Defense Logistics Agency manages the Department of Defense's global...